These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

660 related articles for article (PubMed ID: 3130534)

  • 21. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis.
    Clark D; Hjorth S; Carlsson A
    Eur J Pharmacol; 1984 Oct; 106(1):185-9. PubMed ID: 6099268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitization of rotation behavior in rats with unilateral 6-hydroxydopamine or kainic acid-induced striatal lesions.
    Norman AB; Wyatt LM; Hildebrand JP; Kolmonpunporn M; Moody CA; Lehman MN; Sanberg PR
    Pharmacol Biochem Behav; 1990 Dec; 37(4):755-9. PubMed ID: 2128758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D-2 receptor-mediated inhibition by a substituted quinolinone derivative, 7-[3-(4-(2,3-dimethylphenyl)piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), of dopaminergic neurons in the ventral tegmental area.
    Momiyama T; Sasa M; Takaori S
    Life Sci; 1990; 47(9):761-9. PubMed ID: 1977066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central dopaminergic properties of HW-165 and its enantiomers; trans-octahydrobenzo(f)quinoline congeners of 3-PPP.
    Hjorth S; Svensson K; Carlsson A; Wikström H; Andersson B
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):205-18. PubMed ID: 3762735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptor sites.
    Koch SW; Koe BK; Bacopoulos NG
    Eur J Pharmacol; 1983 Sep; 92(3-4):279-83. PubMed ID: 6138267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presynaptic dopamine receptors: insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol.
    Bannon MJ; Bunney EB; Zigun JR; Skirboll LR; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):161-5. PubMed ID: 6772975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurochemical and behavioral evidence that Ro 41-9067 is a selective presynaptic dopamine receptor agonist.
    Nisoli E; Tonello C; Imhof R; Scherschlicht R; da Prada M; Carruba MO
    J Pharmacol Exp Ther; 1993 Jul; 266(1):97-105. PubMed ID: 8101225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment.
    Hinzen D; Hornykiewicz O; Kobinger W; Pichler L; Pifl C; Schingnitz G
    Eur J Pharmacol; 1986 Nov; 131(1):75-86. PubMed ID: 3816949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated apomorphine treatment causes behavioural supersensitivity and dopamine D2 receptor hyposensitivity.
    Bevan P
    Neurosci Lett; 1983 Feb; 35(2):185-9. PubMed ID: 6222273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-0437: a selective D-2 dopamine receptor agonist in in vitro and in vivo models.
    Van der Weide J; De Vries JB; Tepper PG; Krause DN; Dubocovich ML; Horn AS
    Eur J Pharmacol; 1988 Mar; 147(2):249-58. PubMed ID: 3130270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine receptors mediate drug-induced but not Pavlovian conditioned contralateral rotation in the unilateral 6-OHDA animal model.
    Carey RJ
    Brain Res; 1990 May; 515(1-2):292-8. PubMed ID: 2113414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of apomorphine and (+/-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine, injected into the striatum, on the caudate spindle in the rat.
    Hashimoto S; Okuyama S; Aihara H
    Neuropharmacology; 1987 Jul; 26(7A):663-7. PubMed ID: 2888038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversible decrease in dopaminergic 3H-agonist binding after 6-hydroxydopamine and irreversible decrease after kainic acid.
    Schweitzer BI; Bacopoulos NG
    Life Sci; 1983 Jan; 32(5):531-40. PubMed ID: 6296593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine agonist activity of EMD 23,448.
    Martin GE; Pettibone DJ
    J Neural Transm; 1985; 61(1-2):115-23. PubMed ID: 4038993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneous rotational responsiveness in 6-hydroxydopamine-denervated rats: pharmacological and neurochemical characterization.
    Liebman JM; Gerber R; Hall NR; Altar CA
    Psychopharmacology (Berl); 1988; 96(4):477-83. PubMed ID: 3149769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
    Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
    Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does contralateral circling involve action of drugs on hyposensitive striatal dopamine receptors in the hemisphere contralateral to denervation?
    Costall B; Kelly ME; Naylor RJ
    Neuropharmacology; 1983 Mar; 22(3):295-302. PubMed ID: 6133233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
    Galloway MP; Wolf ME; Roth RH
    J Pharmacol Exp Ther; 1986 Mar; 236(3):689-98. PubMed ID: 3081705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.